Skip to main content
Livermore
Livermore
ZHEN

Citigroup Inc

SEC CIK
0000831001
Latest filing
Aug 3, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AVDL by Citigroup Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−22,579−100.0%Sold outHolders
Q4 202522,579$486.6K<0.1%−2,591−10.3%ReducedHolders
Q3 202525,170$384.3K<0.1%−15,467−38.1%ReducedHolders
Q2 202540,637$359.6K<0.1%−33,135−44.9%ReducedHolders
Q1 202573,772$577.6K<0.1%−8,044−9.8%ReducedHolders
Q4 202481,816$859.9K<0.1%+9,991+13.9%AddedHolders
Q3 202471,825$942.0K<0.1%+46,571+184.4%AddedHolders
Q2 202425,254$355.1K<0.1%+20,591+441.6%AddedHolders
Q1 20244,663$78.8K<0.1%+1,137+32.2%AddedHolders
Q4 20233,526$49.8K<0.1%+896+34.1%AddedHolders
Q3 20232,630$27.1K<0.1%+697+36.1%AddedHolders
Q2 20231,933$31.9K<0.1%+567+41.5%AddedHolders
Q1 20231,366$12.5K<0.1%+637+87.4%AddedHolders
Q4 2022729$5.22K<0.1%+70+10.6%AddedHolders
Q3 2022659$3.00K<0.1%−200−23.3%ReducedHolders
Q2 2022859$2.00K<0.1%−368−30.0%ReducedHolders
Q1 20221,227$8.00K<0.1%−520−29.8%ReducedHolders
Q4 20211,747$14.0K<0.1%−23,015−92.9%ReducedHolders
Q3 202124,762$243.0K<0.1%+21,221+599.3%AddedHolders
Q2 20213,541$24.0K<0.1%+2,427+217.9%AddedHolders
Q1 20211,114$10.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.